- #ASCO26: Yes, Revolution Medicines' pancreatic cancer data are that goodCHICAGO — When oncologist Brian Wolpin saw the positive results from Revolution Medicines' pivotal pancreatic cancer study for the first time, he was rendered speechless, he told Endpoints News.…Endpoints · 1mo ago↗ source
- #ASCO26: Summit, Akeso drug reduces death by 34% in China lung cancer studyCHICAGO — The leading drug in biopharma's hottest immunotherapy race reduced the risk of death by 34% in previously untreated Chinese lung cancer patients, compared to standard immunotherapy plus c…Endpoints · 1mo ago↗ source
- #ASCO26: Personalized cancer vaccines may help brain cancer patients live longerPersonalized cancer vaccines might make notoriously deadly brain cancers more susceptible to immunotherapy and possibly prolong survival for some patients, according to new research from the Dana-F…